UnitedHealthcare made a very public exit from many state Obamacare exchanges last year, scaling back its participation from 34 to just three states.

The debate over just what a pharmaceutical company can say about off-label use of its medications pits free speech rights against the FDA’s mission to protect the public, STAT reports. A bill introduced by Rep.

The FDA has given the nod to ranibizumab injection (Lucentis, Genentech) for the monthly treatment of all forms of diabetic retinopathy.

The FDA has granted accelerated approval to atezolizumab (Tecentriq, Genentech) for the treatment of patients with locally advanced or metastatic urothelial carcinoma (mUC) who are not eligible for cisplatin chemotherapy. This is the third approval for atezolizumab in less than a year.

A new Yahoo News/Marist Poll has addressed the effect of marijuana use on relationships, the changing social norms surrounding the use of the drug, and the debate over its legalization.

The highest-priced drugs have two things in common: they all treat rare diseases, and they all cost hundreds of thousands of dollars per year. A report posted on the Motley Fool website lists the world’s seven most-expensive drugs and the companies that profit from them.

1. Glybera

The Centers for Medicare and Medicaid Services has issued a proposed rule that would adjust the 2018 Medicare payment policies for patient hospital admissions in an effort to reduce the regulatory burden on providers, according to Fierce Healthcare.

Buried within a New York Times article about the costs of nonadherence to prescribed medication—in both financial and human terms—resides yet another argument for value-based health care. Nonadherence “partly explains why new drugs that perform spectacularly well in studies, when patients are monitored to be sure they follow doctors’ orders, fail to measure up once the drug hits the commercial market.”

Positive interim results have been reported from a phase 3 study evaluating emicizumab (Chugai Pharmaceuticals/Genentech/Roche) prophylaxis in children less than 12 years of age with hemophilia A and inhibitors to factor VIII.

The FDA has issued a complete response letter regarding the new drug application (NDA) for baricitinib (Eli Lilly/Incyte Corporation), a once-daily oral medication for the treatment of patients with moderate-to-severe rheumatoid arthritis (RA).

Approximately two million Americans are hooked on prescription opioids or heroin, and an overdose of pain pills kills 91 people every day. Approximately 20 years ago, pharma companies invested heavily in alternative treatments and “failed miserably,” Dr. Nora Volkow, director of the National Institute on Drug Abuse, told Medical Xpress.

The Leapfrog Group, a national nonprofit organization promoting quality and safety in American health care, has announced new grades for the Leapfrog National Safety Grade, the only national health care rating focused on errors, accidents, and infections.

A bill drafted by House Republicans as part of their plan to replace the Patient Protection and Affordable Care Act (PPACA) aims to impose new limits on lawsuits involving care covered by Medicare, Medicaid, or private health insurance subsidized by the PPACA, according to an article in The New York Times.

Researchers in Germany have investigated the possibility of using sperm cells to deliver drugs to cancerous tumors in female patients. In a paper uploaded to the preprint server arXiv, the group describes how such a technique might work, their initial test results, and what they learned from their experiments.

In 1947, researchers investigating yellow fever in East Africa discovered a new virus—Zika—in a sick monkey. The scientists never imagined that 70 years later this virus would spread across several continents, forcing the World Health Organization (WHO) to declare the epidemic a “public health emergency of international concern.”